1Dominic Snijders,Johannes M. A. Daniels,Casper S. de Graaff.Efficacy of Corticosteroids in Community-acquired Pneumonia A Randomized Double-Blinded Clinical Trial. American Journal of Respiratory and Critical Care Medicine . 2010
2Paul Mical,Shani Vered,Muchtar Eli,Kariv Galia,Robenshtok Eyal,Leibovici Leonard.Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrobial Agents and Chemotherapy . 2010
3Bone,RC,Balk,RA,Cerra,FB,Dellinger,RP,Fein,AM,Knaus,WA,Schein,RM,Sibbald,WJ.Definitions for sepsis and organ failure guidelines for the use of innovative therapies in sepsis. Chest . 1992
4Confalonieri M,Urbino R,Potena A,et al.Hydrocortisone infusion for severe community-acquired pneumonia:a preliminary ran-domized study. American Journal of Respiratory and Critical Care Medicine . 2005
5The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis(J)Intensive Care Medicine . 2003 (9)
7M. Shimaoka,E. J. Park.??Advances in understanding sepsis(J)European Journal of Anaesthesiology . 2008
8Sabine CA Meijvis,Hans Hardeman,Hilde HF Remmelts,Rik Heijligenberg,Ger T Rijkers,Heleen van Velzen-Blad,G Paul Voorn,Ewoudt MW van de Garde,Henrik Endeman,Jan C Grutters,Willem Jan W Bos,Douwe H Biesma.??Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial(J)The Lancet . 2011 (9782)
9Hilde H.F. Remmelts,Sabine C.A. Meijvis,Rik Heijligenberg,Ger T. Rijkers,Jan Jelrik Oosterheert,Willem Jan W. Bos,Henrik Endeman,Jan C. Grutters,Andy I.M. Hoepelman,Douwe H. Biesma.??Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia(J)Journal of Infection . 2012 (1)
